Two men, Nick A. (left) and Nigel (right), sit at a white table, engaging in a lively and friendly conversation. Both wear checkered shirts and lavalier microphones, suggesting a filmed discussion or interview. Nick holds tissue samples in one hand and gestures animatedly, while Nigel smiles in response. Each has a white mug labeled with their name and a purple star logo. The background is a bright white, creating a clean and professional studio setting.
Resources

FDA Regulatory Books and PCR Memoirs: End-of-Summer Picks with Nick and Nigel

YouTube video thumbnail

In this Bio Break episode, Nick Allan and Nigel Syrotuck share their end-of-summer reading list, featuring FDA regulatory books and PCR memoirs. From navigating regulatory hurdles to celebrating groundbreaking discoveries, their choices show how science reading can be both educational and entertaining.

FDA Regulatory Reading

Nigel highlights Innovation Breakdown, a book that examines the regulatory processes of the FDA. He explains that while the FDA ensures medical devices are safe and effective, the pathway to approval can be costly and complex. For innovators, this book illustrates both the challenges and safeguards within the FDA system.

PCR Discovery Through Storytelling

Nick’s pick is Dancing Naked in the Minefield by Kary Mullis. This memoir tells the story of polymerase chain reaction (PCR), a discovery that transformed molecular diagnostics. Mullis’s unusual personality and candid storytelling make the book as engaging as it is informative. PCR continues to influence lab testing worldwide, and Nick reflects on its lasting importance.

End-of-Summer Science Picks

Together, Nick and Nigel offer a mix of perspectives: FDA regulatory books that reveal systemic barriers and protections, and scientific memoirs that celebrate creativity and discovery. Their end-of-summer picks capture how reading can deepen our understanding of both process and innovation.

From FDA regulations to PCR breakthroughs, these end-of-summer reads show how science books can spark insight and inspiration.

Businessman holding a glowing compliance icon with legal and regulatory symbols, representing REACH SVHC compliance for medical device manufacturers

Nigel Syrotuck breaks down REACH SVHC compliance for teams working with material suppliers and compliance questionnaires.

Medical Device Design Simulation

We examine when computational modelling and simulation, or CM&S, genuinely supports medical device simulation strategy and when it becomes a costly detour.

Transparent medical device prototype surrounded by computational simulation mesh representing modeling and simulation during medical device development.

Many teams still underuse CM&S, often bringing it late in device validation, when key decisions have already been made. That approach leaves much of the value of CM&S untapped.

Biomedical engineer reviewing a thermal simulation of human head tissue on a monitor, color-mapped from warm to cool gradients

This article traces the Pennes bioheat equation from its 1948 origins to modern multiscale approaches, explaining how engineers select the right level of modelling complexity across device categories.